EGFR is aberrantly expressed or deregulated in tumors through the induction of EMT, playing crucial roles in metastatic progression [33], especially in cholangiocarcinoma [17] and HCC [34]. The gene discussed is EGFR; the disease is hepatocellular carcinoma.